Cited by 405TGF-β signaling in diseasesMechanisms of cancer metastasisCancer Cells and Metastasis

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects

Open access

Yang, Yu-an, Dukhanina, Oksana, Tang, Binwu, Mamura, Mizuko, Letterio, John J., MacGregor, Jennifer, Patel, Sejal C., Khozin, Shahram, Liu, Zi-yao, Green, Jeffrey, Anver, Miriam R., Merlino, Glenn, Wakefield, Lalage M.·2002·Journal of Clinical Investigation

DOI 10.1172/jci200215333PMC PMC151015

Open this paper in CoChat — free account Open PDF

Abstract

TGF-βs play diverse and complex roles in many biological processes. In tumorigenesis, they can function either as tumor suppressors or as pro-oncogenic factors, depending on the stage of the disease. We have developed transgenic mice expressing a TGF-β antagonist of the soluble type II TGF-β receptor:Fc fusion protein class, under the regulation of the mammary-selective MMTV-LTR promoter/enhancer. Biologically significant levels of antagonist were detectable in the serum and most tissues of this mouse line. The mice were resistant to the development of metastases at multiple organ sites when compared with wild-type controls, both in a tail vein metastasis assay using isogenic melanoma cells and in crosses with the MMTV-neu transgenic mouse model of metastatic breast cancer. Importantly, metastasis from endogenous mammary tumors was suppressed without any enhancement of primary tumorigenesis. Furthermore, aged transgenic mice did not exhibit the severe pathology characteristic of TGF-β null mice, despite lifetime exposure to the antagonist. The data suggest that in vivo the antagonist may selectively neutralize the undesirable TGF-β associated with metastasis, while sparing the regulatory roles of TGF-βs in normal tissues. Thus this soluble TGF-β antagonist has potential for long-term clinical use in the prevention of metastasis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci200215333

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Manipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,391
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
Peptide Growth Factors and Their Receptors
Arai, K., Battey, J. F., Sporn, M. B., & Roberts, A. B. (1991) · Medical Entomology and Zoology · Cited by 1,225
Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
Guy, C. T., Webster, M. A., Schaller, M. D., Parsons, T. J., Cardiff, R. D., & Muller, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1
Border, W. A., Okuda, S., Languino, L. R., Sporn, M. B., & Ruoslahti, E. I. (1990) · Nature · doi:10.1038/346371a0 · Cited by 984
Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease
Border, W. A., Noble, N. A., Yamamoto, T., Harper, J. R., Yamaguchi, Y., Pierschbacher, M. D., & Ruoslahti, E. I. (1992) · Nature · doi:10.1038/360361a0 · Cited by 972
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L. R., Lees, E. M., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 964

Show all 50 references

Research works printed but not linked: 4

Gold, 1999, Crit Rev Oncog, 10, 303
Engle, 1999, Cancer Res, 59, 3379
Bottinger, 1997, Cancer Res, 57, 5564
Dalal, 1993, Am J Pathol, 143, 381

Sorted by citations

Items 301–400 of 405

Roles of TGF-β in cancer hallmarks and emerging onco-therapeutic design
Dai, X., Hua, D., & Lu, X. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.37 · Cited by 10
Efficacy of Therapies Targeting TGF-β in Solid Tumors: a Systematic Review and Meta-Analysis of Clinical Trials
Rahavi, H., Alizadeh‐Navaei, R., & Tehrani, M. (2023) · Immunotherapy · doi:10.2217/imt-2022-0079 · Cited by 11
Aberrant expression in multiple components of the transforming growth factor-β1-induced Smad signaling pathway during 7,12-dimethylbenz[a]anthracene-induced hamster buccal-pouch squamous-cell carcinogenesis
Chen, Y.-K., Yang, S., Huang, A. H., Hsue, S., & Lin, L.-M. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.02.003 · Cited by 10
Contact by melanoma cells causes malignant transformation of human epithelial-like stem cells via alpha V integrin activation of transforming growth factor β 1 signaling
Sun, H., Hu, K., Wu, M., Xiong, J., Li, Y., Tang, Y., Yang, Y., & Liu, H. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.010106 · Cited by 10
Self-citation
Suppression of cancer progression and metastasis in HT-29 human colorectal adenocarcinomas by deep sea water
Lee, K., Shin, J.-S., Kwon, Y., Moon, D.-S., & Nam, K. (2013) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-012-0543-y · Cited by 10
QiShenYiQi Attenuates Renal Interstitial Fibrosis by Blocking the Activation of β-Catenin
Zhou, Z., Hu, Z. M., Li, M., Zhu, F., Zhang, H., Nie, J., & Ai, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162873 · Cited by 10
Retracted
Animal Models of Colorectal Cancer in Chemoprevention and Therapeutics Development
Suman, S., Fornace, A. J., & Datt, K. (2012) · InTech eBooks · doi:10.5772/28497 · Cited by 9
Targeting Transforming Growth Factor β to Enhance Cancer Immunotherapy
Hahn, T., & Akporiaye, E. T. (2006) · Current Oncology · doi:10.3390/curroncol13040015 · Cited by 12
Disruption of the TGF-β pathway and modeling human cancer in mice
Letterio, J. J. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.03.004 · Cited by 9
Self-citation
Long non‑coding RNA SNHG20 promotes nasopharyngeal carcinoma cell migration and invasion by upregulating TGF‑β1
Sun, C., Sun, Y., & Endong, Z. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6849 · Cited by 8
Enhancing Antitumor Immunity: Combining IL-12 With TGFβ1 Antagonism
Fan, T. M., Kranz, D. M., & Roy, E. J. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318031a2b2 · Cited by 8
Current and Future Intratumoral Targeted Treatment for Pancreatic Cancer
Zarogoulidis, P., Pavlioglou, P., Pivert, P. J. M. L., Machairiotis, N., Katsikogiannis, N., Kougioumtzi, I., Tsimogiannis, K. E., Kakolyris, S., Courcoutsakis, N. A., Tsiouda, T., et al. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.44 · Cited by 8
Ecoevolutionary biology of pancreatic ductal adenocarcinoma
Arul, G. L. R., Toruner, M. D., Gatenby, R. A., & Carr, R. M. (2022) · Pancreatology · doi:10.1016/j.pan.2022.06.005 · Cited by 9
The soluble transforming growth factor-β receptor: Advantages and applications
Russo, L. M., Brown, D., & Lin, H. Y.-F. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.01.026 · Cited by 7
Dangerous liaisons
Balmain, A., & Akhurst, R. J. (2004) · Nature · doi:10.1038/428271a · Cited by 7
TGF-β antagonists: Why suppress a tumor suppressor?
Akhurst, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215970 · Cited by 7
Mammary Gland Cancer
Barkan, D., Montagna, C., Ried, T., & Green, J. E. (2004) · doi:10.1002/0471675067.mmc007 · Cited by 7
Self-citation
Role of TGF-β signaling in EMT, cancer progression and metastasis
Savary, K., & Moustakas, A. (2011) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2011.07.009 · Cited by 6
Black Tea-Induced Decrease in IL-10 and TGF-β of Tumor Cells Promotes Th1/Tc1 Response in Tumor Bearer
Mandal, D. P., Bhattacharyya, S., Lahiry, L., Chattopadhyay, S., Sa, G., & Das, T. (2007) · Nutrition and Cancer · doi:10.1080/01635580701328503 · Cited by 6
Modulation of TGF-β signaling by EGF-CFC proteins
Wechselberger, C., Bianco, C., Strizzi, L., Ebert, A. D., Kenney, N. J., Sun, Y., & Salomon, D. S. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.023 · Cited by 6
Son of a mother against decapentaplegic
Luft, F. C. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0404-9 · Cited by 6
Chemotherapeutic targeting of the TGF-β pathway in breast cancers
Lee, Y., & Schiemann, W. P. (2013) · Breast Cancer Management · doi:10.2217/bmt.13.74 · Cited by 6
Inhibition of the TGF-β Signaling Pathway in Tumor Cells
Podar, K., Raje, N. S., & Anderson, K. C. (2007) · Springer eBooks · doi:10.1007/978-3-540-31209-3_6 · Cited by 5
A microscale assay for the identification of TGF-β antagonists based on functional coupling of the heterodimeric TGF-β receptor to STAT6-driven promoter activation
Krause, S., & Friedrich, K. (2005) · Signal Transduction · doi:10.1002/sita.200400042 · Cited by 6
New Entrants into Clinical Trials for Targeted Therapy of Breast Cancer: An Insight
Verma, P., Mittal, P., Singh, A. K., & Singh, I. K. (2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666191018172926 · Cited by 5
General Principles of Tumor Immunotherapy
Kaufman, H. L., & Wolchok, J. D. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8 · Cited by 15
Engineering DNA Origami Captors for TGFβ1 Sequestration to Enhance Tumor Immune Modulation and Therapy
Chen, X., Liu, D., Jin, J., Yao, H., Yao, S., Liu, Y., Sun, J., & Yang, Y. (2025) · Advanced Science · doi:10.1002/advs.202506827 · Cited by 5
Self-citation
A preserved TGFβ cytostatic response through DLD-mediated metabolic modulation undermines anti-TGFβ therapy in gastric cancer
Pan, Y., Han, Y., Qian, Z.-Y., Zhang, X. M., Wang, T., Cai, Z., Chen, H., Li, Y., Liao, K. L., Zheng, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64997-5 · Cited by 4
Self-citation
Small Molecule Antagonists of the TGF-β1/TGF-β Receptor Binding Interaction
Burmester, J. K., Salzman, S. A., Zhang, K. Q., & Dart, R. A. (2006) · Medical Oncology · doi:10.1385/mo:23:4:553 · Cited by 4
Innovative combinatory approaches with dendritic cell-based vaccines: bridging preclinical insights and clinical challenges
Khanmiri, J. M., Khani-Eshratabadi, M., Seyedmoharrami, F., Khazaee‐Nasirabadi, M. H., Dehdashti, M., Seddighi, N., Peymaninezhad, F., Khiabani, A., Khanahmad, A., & Baradaran, B. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02056-z · Cited by 5
Transforming Growth Factor‐Beta Signaling in Cancer: Therapeutic Implications, Challenges, and Pathways to Progress
Alabi, F. A., Okpalanwaka, I. F., Oyegbesan, A., Okoyeocha, E. O. M., Oladejo, M., & Imodoye, S. O. (2025) · MedComm – Oncology · doi:10.1002/mog2.70027 · Cited by 3
Dynamic Regulation of Adherens Junctions: Implication in Cell Differentiation and Tumor Development
Pelissier-Rota, M. A., Chartier, N. T., & Jacquier‐Sarlin, M. R. (2015) · Springer eBooks · doi:10.1007/978-94-017-7380-5_4 · Cited by 3
Keeping neuroendocrine cells in check: roles for TGFβ, Smads, and menin?
Dockray, G. J. (2003) · Gut · doi:10.1136/gut.52.9.1237 · Cited by 3
Transforming growth factor-β signaling helps specify tumor type in DMBA and hormone-induced mammary cancers
Crowley, M. R., Frost, A. R., Chen, D., Baffi, M. O., Nicola, T., & Serra, R. A. (2006) · Differentiation · doi:10.1111/j.1432-0436.2006.00056.x · Cited by 3
A fitted operator method for tumor cells dynamics in their micro-environment
Owolabi, K. M., Kailash, P., & Shikongo, A. (2019) · Communications in Mathematical Biology and Neuroscience · doi:10.28919/cmbn/3885 · Cited by 3
Oral Submucous Fibrosis: Revised Hypotheses as to its cause
Rajendran, R., & Sukumaran, A. (2013) · The Journal of Contemporary Dental Practice · doi:10.5005/jcdp-14-5-i · Cited by 3
The TGFβ and Androgen Receptor Signaling Pathways Converge to Support Anoikis Resistance in Triple Negative Breast Cancer
Rosas, E., & Richer, J. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-73856-3_9 · Cited by 3
Transforming Growth Factor-β (TGF-β) Signaling Inhibitors in Cancer Therapy
Datta, P. K., & Mann, J. R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_35 · Cited by 3
In vivo electron spin resonance spectroscopy: what use is it to gastroenterologists?
Dhanjal, N. S., Cox, I. J., & Taylor-Robinson, S. D. (2003) · Gut · doi:10.1136/gut.52.9.1236 · Cited by 2
Rationale for Anti-TGF-β Antibody Therapy in Oncology
Hsu, F. J., Teicher, B. A., & McPherson, J. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_46 · Cited by 2
Engineering TGF-β Traps: Artificially Dimerized Receptor Ectodomains as High-affinity Blockers of TGF-β Action
Crescenzo, G. D., Chao, H., Zwaagstra, J. C., Durocher, Y., & O'Connor‐McCourt, M. D. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_40 · Cited by 2
Transforming Growth Factor-Beta in Prostate Cancer
Danielpour, D. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6828-8_7 · Cited by 2
Reversal of EMT by Small-Molecule Inhibitors of TGF-β Type I and II Receptors: Implications for Carcinoma Treatment
Lacher, M. D., Korn, W. M., & Akhurst, R. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_43 · Cited by 2
Targeting Transforming Growth Factor-β in Metastasis: In Vitro and In Vivo Mechanisms
Reiß, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_37 · Cited by 2
Homeless Cells Escape Death and Deliver Lethal Cancer
Archer, M., & Kyprianou, N. (2021) · Endocrinology · doi:10.1210/endocr/bqab027 · Cited by 1
Frontiers of Cancer Research: The Metastasis Challenge
John, S., Stuelten, C. H., & Niederhuber, J. E. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-087-8_1 · Cited by 1
A Primer on Organizational Ethics and Leadership for Professional School Counselors
Avilés, B. D., & Skaggs, J. L. (2012) · Cited by 1
TGFβ and BMP signaling in cancer
Papageorgis, P., Lambert, A. W., Ozturk, S., & Thiagalingam, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.015 · Cited by 1
Ultrasound and microbubble targeted delivery
Meijering, B. D. M. (2009) · Cited by 1
Gene Regulation Network Based Analysis Associated with TGF-beta Stimulation in Lung Adenocarcinoma Cells
Hua, L., Xia, H., Zheng, W., & An, L. (2017) · Iranian Journal of Biotechnology · doi:10.15171/ijb.1308 · Cited by 1
TGF-β Signaling Pathway and Its Therapeutic Role in Cancer
James, A. W., Bhat, H. M., Yousuf, S., Jan, M., Rehman, M. U., & Rashid, S. M. (2025) · Springer eBooks · doi:10.1007/978-981-96-2763-9_11 · Cited by 1
Targeting Pro-Angiogenic TGF-β Signaling in the Tumor Microenvironment
Pietras, K., & Cunha, S. I. (2013) · Springer eBooks · doi:10.1007/978-4-431-54409-8_19 · Cited by 1
TGF-β Signaling in Fibroblastic Cells and Oncogenesis
Bhowmick, N. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-292-2_12 · Cited by 1
Molecular Relationships Between Chronic Pancreatitis and Cancer
Logsdon, C. D., Ji, B., & Hwang, R. F. (2009) · Springer eBooks · doi:10.1007/978-0-387-77498-5_11 · Cited by 1
Transforming Growth Factor-β Signal Transduction in the Pathogenesis of Diabetic Nephropathy
Chen, S., & Ziyadeh, F. N. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-153-6_12 · Cited by 1
Breast cancer secreted factors alter the bone microenvironment
Siclari, V. A., Guise, T. A., & Chirgwin, J. M. (2007) · Cancer metastasis · doi:10.1007/978-1-4020-5867-7_12 · Cited by 1
MOLECULAR REGULATION OF THE TUMOR KILLING ACTIVITY OF DENDRITIC CELLS
Hanke, N. T. (2012) · UA Campus Repository (The University of Arizona) · Cited by 1
Tumor Suppressor and Pro-progression Roles for TGF-β in Breast Cancer
Kohn, E. A., & Tang, B. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_19 · Cited by 1
Self-citation
Modulating TGF-β Receptor Signaling: A Novel Approach of Cancer Therapy
Naumann, U., & Weller, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_39
Gene Expression Signatures of TGF-β/Smad-Induced Responses
Böttinger, E. P., & Ju, W. (2007) · Springer eBooks · doi:10.1007/1-4020-4709-6_17
High-Throughput Screening of Protein Interaction Networks in the TGFβ Interactome: Understanding the Signaling Mechanisms Driving Tumor Progression
Barrios‐Rodiles, M., Viloria‐Petit, A., Brown, K. R., Jurišica, I., & Wrana, J. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_18
Smads in the Fibrotic Response: Findings in the Smad3 Knockout Mouse
Flanders, K. C. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-292-2_37
Disruption of Transforming Growth Factor-beta Signaling Using a Small Molecule TGF-beta Receptor Type I Kinase Inhibitor Improves the Efficacy of Dendritic Cell Vaccines
Rausch, M. P. (2008) · UA Campus Repository (The University of Arizona)
Transcription Factors in the Control of Tumor Development and Progression by TGF-β Signaling
Timokhina, I., Lecanda, J., & Kretzschmar, M. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18932-6_6
Soluble Type II Transforming Growth Factor-β Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity
Suzuki, E., & Albelda, S. Μ. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_42
Functional networks of events that modulate phenotypic manifestation of cancer
Thiagalingam, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.012
Role of TGF-β in Osteolytic Bone Metastases
Bartholin, L., & Guise, T. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_7
Role of TGF-β in Tumor Progression and Metastasis
Pinkas, J., & Teicher, B. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-035-5_25
Preclinical Evaluation of Serine/Threonine Kinase Inhibitors Against Prostate Cancer Metastases
Guise, T. A. (2005) · doi:10.21236/ada462851
Role of TGF-β in Tumor Protection and Antitumor Immunity
Bollard, C. M., & Rooney, C. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_25
Immunomodulatory Molecules of the Immune System
Saenger, Y. M., Jenq, R. R., & Perales, M. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8_5
Targeting the TGF-β Pathway In Vivo
Wolfraim, L. A., Mamura, M., Roberts, A. B., & Letterio, J. J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-405-4_24
Self-citation
Aberration of a TGF-.BETA. Signaling Molecule, Smad4, in Oral Squamous Cell Carcinoma
Iamaroon, A., Pattamapun, K., & Piboonniyom, S.-O. (2005) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.14.221
Surgical removal of the primary?—The role it plays in stage IV breast cancer
Fitzal, F. (2012) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-012-0024-1
Regulation of TGF-β Signaling and Metastatic Progression by Tumor Microenvironments
Wendt, M. K., & Schiemann, W. P. (2011) · Springer eBooks · doi:10.1007/978-94-007-2558-4_5
Expression of Transforming Growth Factor β1 and Cadherins in Lung Adenocarcinoma
Park, S. Y., & Yoo, J. (2012) · Journal of Lung Cancer · doi:10.6058/jlc.2012.11.1.38
Modeling Transforming Growth Factor-ß Signaling in Cancer
Placencio, V. R., & Bhowmick, N. A. (2011) · Springer eBooks · doi:10.1007/978-0-387-69805-2_19
Transforming Growth Factor-beta and Smad4 Regulation of Invasive and Metastatic Behavior in Cancer Cells
Shiou, S. (2006) · Europe PMC (PubMed Central)
Dendritic Cells for Cancer Immunotherapy
Larmonier, N., & Katsanis, E. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-417-3_11
β Signaling Molecule, Smad4, in Oral Squamous Cell Carcinoma
Iamaroon, A., Pattamapun, K., & Piboonniyom, S.-O. (2005)
Targeting Smad-Dependent TGF-β Signaling with Peptide Aptamers
Hoffmann, F. M., Cui, Q., Lim, S. K., & Zhao, B. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_45
Novel aspects of TGFβ in human CD4 + T cell biology
Bonn, R. F.-W.-U. (2008)
Triterpenoids, Vitamin D, and TGF-β/Smad Signaling in Inflammation and Cancer
Suh, N. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-292-2_33
Dissecting the molecular mechanisms of breast cancer bone metastasis for therapeutic targeting
Pollari, S. (2012) · UTUPub (University of Turku)
A Mechanism and Pro-migratory Function for Non-canonical TGFβ Signaling Through
Liu, I. M. (2008)
Targeting the TGFβ signalling pathway in disease
Family, H. D. (2012)
Role of Adrenomedullin in Breast Cancer Bone Metastasis and Chemoresistance
Siclari, V. A. (2007) · Defense Technical Information Center (DTIC) · doi:10.21236/ada470977
Transforming Growth Factor-β Signaling in Pancreas Development and Pancreatic Disease
Rane, S. G., Lin, H., & Lee, J.-H. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_1
The role of epithelial to mesenchymal transition in the development of bronchiolitis obliterans syndrome in lung transplant recipients
Banerjee, B. (2011) · UWA Profiles and Research Repository (UWA)
Adoptive T-cell Therapy
Morgan, R. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00017-8
Role of TGF-β signaling in carcinoma cell migration and tumor progression
Matise, L. A. (2012)
TGFβ Signaling in Head and Neck Cancer Development and Metastases
Malkoski, S. P., Lighthall, J. G., & Wang, X.-J. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0775-2_8
Mechanisms for TGF-β-Mediated Regulation of the Actin Filament System and Apoptosis
Edlund, S. (2003) · Uppsala University Publications (Uppsala University)
Faculty Opinions recommendation of Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
Whitman, M. (2003) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1015355.196551
Development of Oncolytic Adenovirus Armed with a Fusion of Soluble Transforming Growth Factor- ? Receptor II and Human Immunoglobulin Fc for Breast Cancer Therapy
Seth, P. K., Wang, Z., Pister, A., Zafar, M. B., Kim, S. H., Guise, T. A., & Wakefield, L. M. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-252
Self-citation
Numerical Solution for a Tumor Cells Dynamics Within Their Micro-environment
Owolabi, K. M., Shikongo, A., & Pindza, E. (2023) · Studies in computational intelligence · doi:10.1007/978-981-99-5001-0_3
Tumor microenvironment and metastatic progression of cancer
Hong, E., Park, S., Kim, S., & Ooshima, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824040-3.00006-6
Adoptive Transfer of Tumor Reactive TGF-β Insensitive CD8+ T-cells for Cancer Therapy
Lee, C., Shah, A. H., Liu, V. C., Park, I. I., Wong, L. Y., Huang, X., Huang, L., Zhou, V., Medler, T. R., KUNDU, S. D., et al. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_28
Perturbations of TGF-β Signaling in Leukocytes as Drivers of Leukemogenesis and Epithelial Tumorigenesis
Wolfraim, L. A., & Letterio, J. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_13
Self-citation
Rol del factor de crecimiento transformante beta en la progresión del cáncer de pulmón
Carlini, M. J. (2013) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)

Authors: Yang, Y.-A., Dukhanina, O., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J., Anver, M. R., Merlino, G., & Wakefield, L. M.
Affiliations: National Institutes of Health (US)
Frederick National Laboratory for Cancer Research (US)
Corresponding author: Wakefield, Lalage M.
ORCID: Mamura, Mizuko
Letterio, John J.
Green, Jeffrey
Anver, Miriam R.
Merlino, Glenn
Wakefield, Lalage M.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2002-06-15
Volume: 109
Issue: 12
Pages: 1607-1615
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci200215333
PMC: PMC151015
OpenAlex: W2118916648
Cited by: 404
References: 50
Citations by year: 2026: 1 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 8 · 2020: 9 · 2019: 5 · 2018: 5 · 2017: 6 · 2016: 8 · 2015: 9 · 2014: 17 · 2013: 19 · 2012: 30
FWCI: 12.90
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Health and Human Services
National Institutes of Health (n01co12400-79-0-22, NO1-CO12400)
National Cancer Institute (N01CO12400, N01-CO-012400, NO1‐CO‐12400)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords: TGF-beta antagonists, Fc fusion protein, metastasis prevention, melanoma metastasis, MMTV-neu transgenic mice, breast cancer, transgenic mice
MeSH terms: Receptor, Transforming Growth Factor-beta Type II, Animals, Female, Genetic Vectors, Humans, Immunoglobulin G, Immunoglobulin Fc Fragments, Liver Neoplasms, Mammary Tumor Virus, Mouse, Melanoma, Experimental, Mice, Transgenic, Neoplasm Metastasis, Recombinant Fusion Proteins, Solubility, Tumor Cells, Cultured, Mammary Neoplasms, Animal, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Receptors, Transforming Growth Factor beta, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks